Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.
Information source: Kuopio University Hospital
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: remifentanil (Drug); remifentanil (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Kuopio University Hospital Official(s) and/or principal investigator(s):
Pasi Lahtinen, MD, Study Director, Affiliation: Department of Anesthesiology and Intensive Care, Kuopio University hospital, Kuopio, Finland
Overall contact:
Pasi Lahtinen, MD, Phone: +358-40-7368286, Email: pasi.lahtinen@kuh.fi
Summary
Prospective double blind study comparing two remifentanil dosing protocols (0. 1 and 0. 3
mcg/kg/min) during cardiac surgery. Main outcome measures are postoperative opioid
requirements (PCA oxycodone) and postoperative pain (VAS, verbal rating scale).
Clinical Details
Official title: Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.
Study design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Primary outcome: Postoperative opioid (oxycodone) consumption
Eligibility
Minimum age: 18 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Coronary artery bypass grafting patients
Exclusion Criteria:
- Psychiatric disorders, sleep apnea, cardiac insufficiency
Locations and Contacts
Pasi Lahtinen, MD, Phone: +358-40-7368286, Email: pasi.lahtinen@kuh.fi
Kuopio University hospital, Kuopio 70210, Finland; Recruiting
Pasi Lahtinen, Email: pasi.lahtinen@kuh.fi
Tadeusz Musialowicz, MD, Sub-Investigator
Additional Information
Starting date: September 2008
Ending date: March 2011
Last updated: October 15, 2009
|
